Corrigendum: Cost and effectiveness of combination nicotine replacement therapy among heavy smokers contacting a quitline (Journal of Smoking Cessation (2014) DOI: 10.1017/jsc.2014.15);Cost and Effectiveness of Combination Nicotine Replacement Therapy among Heavy Smokers Contacting a Quitline

Journal of Smoking Cessation

Volumn 11, Issue 1, 2014, Pages 50-59

  Krupski, Laurie ^a   Cummings, K Michael ^b   Hyland, Andrew ^a   Mahoney, Martin C ^a   Toll, Benjamin A ^c   Carpenter, Matthew J ^b   Carlin Menter, Shannon ^d  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c YALE CANCER CENTER   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956748767     PISSN: None     EISSN: 18342612     Source Type: Journal    
DOI: 10.1017/jsc.2015.1     Document Type: Erratum

References (37)

1. An, L., Betzner, A., Luxenberg, M. L., Rainey, J., Capesius, B. A., Subialka, E. (2009). Measuring Quit Rates: Quality Improvement Initiative Phoenix: North American Quitline Consortium.
2. An, L. C., Schillo, B. A., Kavanaugh, A. M., Lachter, R. B., Luxenberg, M. G.,Wendling, A. H., Joseph, A. M. (2006). Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tobacco Control, 15(4), 286-293. http://dx.doi.org/10.1136/tc.2005.014555
3. Bauer, J.E., Carlin-Menter, S.M., Celestino, P.B., Hyland, A., Cummings, K. M. (2006). Giving away free nicotine medications and a cigarette substitute (Better Quit) to promote calls to a quitline. Journal of Public Health Management & Practice, 12(1), 60-67. http://dx.doi.org/10.1097/00124784-200601000-00012
4. Bolt, D. M., Piper, M. E., Theobald,W. E., Baker, T. B. (2012). Why two smoking cessation agents work better than one: role of craving suppression. Journal of Consulting & Clinical Psychology, 80(1), 54-65. http://dx.doi.org/10.1037/a0026366
5. Borland, R., Yong, H.H., O'Connor, R.J., Hyland, A., Thompson, M. E. (2010). The reliability and predictive validity of theHeaviness of Smoking Index and its two components: findings from the International Tobacco Control Four Country study.Nicotine & Tobacco Research, 12 Suppl, S45-50. http://dx.doi.org/10.1093/ntr/ntq038
6. Browning, K.K., Ferketich, A.K., Salsberry, P. J., Wewers, M. E. (2008). Socioeconomic disparity in providerdelivered assistance to quit smoking. Nicotine & Tobacco Research, 10(1), 55-61. http://dx.doi.org/10.1080/14622200701704905
7. Carlin-Menter, S., Cummings, K. M., Celestino, P., Hyland, A., Mahoney, M. C., Willett, J., Juster, H. R. (2011). Does offering more support calls to smokers influence quit success? Journal of Public Health Management & Practice, 17(3), E9-15. http://dx.doi.org/10.1097/PHH.0b013e318208e730
8. Carpenter, MJ, J. B., Burris, J. L., Matthew, A. R., Schnoll, R. A., Rigotti, N. A et al. (2013). Clinical Strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: A review of the literature. Drugs, 73, 407-426. http://dx.doi.org/10.1007/s40265-013-0038-y
9. Centers for Disease, C., Prevention, (2011). Current cigarette smoking prevalence among working adults-United States, 2004-2010. MMWR-Morbidity & Mortality Weekly Report, 60(38), 1305-1309.
10. Cummings, K. M., Fix, B., Celestino, P., Carlin-Menter, S., O'Connor, R.,&Hyland,A. (2006). Reach, efficacy, and costeffectiveness of free nicotinemedication giveaway programs. Journal of Public Health Management & Practice, 12(1), 37-43. http://dx.doi.org/10.1097/00124784-200601000-00009
11. Cummings, K. M., Hyland, A., Carlin-Menter, S., Mahoney, M. C., Willett, J., Juster, H. R. (2011). Costs of giving out free nicotine patches through a telephone quit line. Journal of Public Health Management & Practice, 17(3), E16-23. http://dx.doi.org/10.1097/PHH.0b013e3182113871
12. Fagerstrom, K. O., Schneider, N. G., Lunell, E. (1993). Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology, 111(3), 271-277. http://dx.doi.org/10.1007/BF02244941
13. Ferguson, S. G., Shiffman, S. (2009). The relevance and treatment of cue-induced cravings in tobacco dependence. Journal of Substance Abuse Treatment, 36(3), 235-243. http://dx.doi.org/10.1016/j.jsat.2008.06.005
14. Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., Swan, G. E. (2003). Measures of abstinence in clinical trials: issues and recommendations. Nicotine & Tobacco Research, 5(1), 13-25. http://dx.doi.org/10.1093/ntr/5.1.13
15. Hurt, R. D., Ebbert, J. O., Hays, J. T., McFadden, D.D. (2009). Treating tobacco dependence in a medical setting. CA: a Cancer Journal for Clinicians, 59(5), 314-326. http://dx.doi.org/10.3322/caac.20031
16. Kozlowski, L. T., Porter, C. Q., Orleans, C. T., Pope, M. A., Heatherton, T. (1994). Predicting smoking cessation with self-reportedmeasures of nicotine dependence: FTQ, FTND, and HSI. Drug & Alcohol Dependence, 34(3), 211-216. http://dx.doi.org/10.1016/0376-8716(94)90158-9
17. Lerman, C., Jepson, C., Wileyto, E.P., Patterson, F., Schnoll, R., Mroziewicz, M. et al. Genetic variation in nicotine metabolism predicts the efficacy of extendedduration transdermal nicotine therapy. Clinical pharmacology and therapeutics, (2010); 87(5), 553-557. http://dx.doi.org/10.1038/clpt.2010.3
18. Lichtenstein, E., Zhu, S.-H., Tedeschi, G. J. (2010). Smoking cessation quitlines: an under recognized intervention success story. American Psychologist, 65(4), 252-261. http://dx.doi.org/10.1037/a0018598
19. Loh,W.-Y., Piper, M. E., Schlam, T. R., Fiore,M. C., Smith, S. S., Jorenby, D. E., Baker, T. B. (2012). Should all smokers use combination smoking cessation pharmacotherapy? Using novel analyticmethods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine & Tobacco Research, 14(2), 131-141. http://dx.doi.org/10.1093/ntr/ntr147
20. McAfee, T. A., Bush, T., Deprey, T. M., Mahoney, L. D., Zbikowski, S. M., Fellows, J. L., McClure, J. B. (2008). Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks. American Journal of PreventiveMedicine, 35(2), 103-110. http://dx.doi.org/10.1016/j.amepre.2008.04.017
21. McClave, A. K., Whitney, N., Thorne, S. L., Mariolis, P., Dube, S. R., Engstrom, M., Prevention, (2010). Adult tobacco survey-19 States, 2003-2007. Morbidity & Mortality Weekly Report, Surveillance Summaries. 59(3), 1-75.
22. Paul, C. L., Ross, S., Bryant, J., Hill, W., Bonevski, B., Keevy, N. (2010). The social context of smoking: A qualitative study comparing smokers of high versus low socioeconomic position. BMC Public Health, 10, 211. http://dx.doi.org/10.1186/1471-2458-10-211
23. Piper, M.E., Cook, J.W., Schlam, T.R., Jorenby, D.E., Smith, S. S., Bolt, D. M., Loh, W.-Y. (2010). Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine & Tobacco Research, 12(6), 647-657. http://dx.doi.org/10.1093/ntr/ntq067
24. Piper, M. E., Smith, S. S., Schlam, T. R., Fiore, M. C., Jorenby, D. E., Fraser, D., Baker, T. B. (2009). A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. [Erratum appears in Arch Gen Psychiatry. 2010 Jan; 67(1):77 Note: Dosage error in article text]. Archives of General Psychiatry, 66(11), 1253-1262. http://dx.doi.org/10.1001/archgenpsychiatry.2009.142
25. Shah, S. D., Wilken, L. A., Winkler, S. R., Lin, S.-J. (2008). Journal of the American Pharmacists Association: JAPhA, 48(5), 659-665. http://dx.doi.org/10.1331/JAPhA.2008.07063
26. Shiffman, S. (2008). Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Clinical Therapeutics, 30(8), 1461-1475. http://dx.doi.org/10.1016/j.clinthera.2008.07.019
27. Shiffman, S., Di Marino, M. E., Pillitteri, J. L. (2005). The effectiveness of nicotine patch and nicotine lozenge in very heavy smokers. Journal of Substance Abuse Treatment, 28(1), 49-55. http://dx.doi.org/10.1016/j.jsat.2004.10.006
28. Smith, S. S., Keller, P. A., Kobinsky, K. H., Baker, T. B., Fraser, D. L., Bush, T., Fiore, M. C. (2013). Enhancing Tobacco Quitline Effectiveness: Identifying a Superior Pharmacotherapy Adjuvant. Nicotine & Tobacco Research, 15(3), 718-728. http://dx.doi.org/10.1093/ntr/nts186
29. Smith, S. S., McCarthy, D. E., Japuntich, S. J., Christiansen, B., Piper, M.E., Jorenby, D.E., Jackson, T.C. (2009). Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Archives of Internal Medicine, 169(22), 2148-2155. http://dx.doi.org/10.1001/archinternmed.2009.426
30. Schneider, N. G., Cortner, C., Justice, M., Gould, J. L., Amor, C., Hartman, N., Olmstead, R. (2008). Preferences among five nicotine treatments based on information versus sampling. Nicotine & Tobacco Research, 10(1), 179-186. http://dx.doi.org/10.1080/14622200701767837
31. Schneider, N.G., Koury, M.A., Cortner, C., Olmstead, R.E., Hartman, N., Kleinman, L., Leaf, D. (2006). Preferences among four combination nicotine treatments. Psychopharmacology, 187(4), 476-485. http://dx.doi.org/10.1007/s00213-006-0449-5
32. Schnoll, R. A., Leone, F. T. (2011) Biomarkers to optimize the treatment of nicotine dependence. Biomarkers in Medicine, 5(6):745-761. http://dx.doi.org/10.2217/bmm.11.91
33. Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., Lancaster, T. (2012). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, 11, CD000146. http://dx.doi.org/10.1002/14651858.CD000146.pub4
34. Tinkelman,D.,Wilson, S. M.,Willett, J.,&Sweeney, C. T. (2007). Offering free NRT through a tobacco quitline: impact on utilization and quit rates. Tobacco Control, 16 Suppl 1, i42-46. http://dx.doi.org/10.1136/tc.2007.019919
35. Treating tobacco use and dependence 2008 update. (2008). U.S. Dept. of Health and Human Services Public Health Service: Rockville, Md.
36. Vidrine, J., Reitzel, L., Wetter, D. (2009). Smoking and health disparities. Current Cardiovascular Risk Reports, 3(6), 403-408. http://dx.doi.org/10.1007/s12170-009-0060-5
37. Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., Thun, M. (2004). Cancer Disparities by Race/Ethnicity and Socioeconomic Status. CA: A Cancer Journal for Clinicians, 54(2), 78-93. http://dx.doi.org/10.3322/canjclin.54.2.78